<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Adv Nutr</journal-id>
<journal-id journal-id-type="iso-abbrev">Adv Nutr</journal-id>
<journal-id journal-id-type="publisher-id">advances</journal-id>
<journal-title-group>
<journal-title>Advances in Nutrition</journal-title>
</journal-title-group>
<issn pub-type="ppub">2161-8313</issn>
<issn pub-type="epub">2156-5376</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30721960</article-id>
<article-id pub-id-type="pmc">6363528</article-id>
<article-id pub-id-type="doi">10.1093/advances/nmy078</article-id>
<article-id pub-id-type="publisher-id">nmy078</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Supplement</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Diet, Gut Microbiota, and Obesity: Links with Host Genetics and Epigenetics and Potential Applications</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Cuevas-Sierra</surname>
<given-names>Amanda</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ramos-Lopez</surname>
<given-names>Omar</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-1885-8457</contrib-id>
<name>
<surname>Riezu-Boj</surname>
<given-names>Jose I</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-3228-9916</contrib-id>
<name>
<surname>Milagro</surname>
<given-names>Fermin I</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0003-2631-2566</contrib-id>
<name>
<surname>Martinez</surname>
<given-names>J Alfredo</given-names>
</name>
<!--<email>jalfmtz@unav.es</email>-->
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff4">4</xref>
<xref ref-type="corresp" rid="cor1"></xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label>Department of Nutrition, Food Science, and Physiology and Center for Nutrition Research, University of Navarra, Pamplona, Spain</aff>
<aff id="aff2"><label>2</label>Navarra Institute for Health Research (IdiSNA), Pamplona, Spain</aff>
<aff id="aff3"><label>3</label>Centro de Investigacion Biomedica en Red Fisiopatologia de la Obesidad y Nutricion (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain</aff>
<aff id="aff4"><label>4</label>Madrid Institute of Advanced Studies (IMDEA Food), Madrid, Spain</aff>
<author-notes>
<corresp id="cor1">Address correspondence to JAM (e-mail: <email>jalfmtz@unav.es</email>)</corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date iso-8601-date="2019-02-05" pub-type="epub">
<day>05</day>
<month>2</month>
<year>2019</year>
</pub-date>
<volume>10</volume>
<issue>Suppl 1</issue>
<fpage>S17</fpage>
<lpage>S30</lpage>
<history>
<date date-type="received">
<day>21</day>
<month>6</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>09</day>
<month>8</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>9</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Â© 2019 American Society for Nutrition.</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="oup-standard" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">
<license-p>This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model</ext-link>)</license-p>
</license>
</permissions>
<self-uri xlink:href="nmy078.pdf"></self-uri>
<abstract>
<title>ABSTRACT</title>
<p>Diverse evidence suggests that the gut microbiota is involved in the development of obesity and associated comorbidities. It has been reported that the composition of the gut microbiota differs in obese and lean subjects, suggesting that microbiota dysbiosis can contribute to changes in body weight. However, the mechanisms by which the gut microbiota participates in energy homeostasis are unclear. Gut microbiota can be modulated positively or negatively by different lifestyle and dietary factors. Interestingly, complex interactions between genetic background, gut microbiota, and diet have also been reported concerning the risk of developing obesity and metabolic syndrome features. Moreover, microbial metabolites can induce epigenetic modifications (i.e., changes in DNA methylation and micro-RNA expression), with potential implications for health status and susceptibility to obesity. Also, microbial products, such as short-chain fatty acids or membrane proteins, may affect host metabolism by regulating appetite, lipogenesis, gluconeogenesis, inflammation, and other functions. Metabolomic approaches are being used to identify new postbiotics with biological activity in the host, allowing discovery of new targets and tools for incorporation into personalized therapies. This review summarizes the current understanding of the relations between the human gut microbiota and the onset and development of obesity. These scientific insights are paving the way to understanding the complex relation between obesity and microbiota. Among novel approaches, prebiotics, probiotics, postbiotics, and fecal microbiome transplantation could be useful to restore gut dysbiosis.</p>
</abstract>
<kwd-group kwd-group-type="keywords">
<kwd>endotoxemia</kwd>
<kwd>prebiotics</kwd>
<kwd>dysbiosis</kwd>
<kwd>SCFA</kwd>
<kwd>postbiotics</kwd>
<kwd>epigenetics</kwd>
</kwd-group>
<counts>
<page-count count="14"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>